Bromocriptine and insulin sensitivity in lean and obese subjects

Autor: L Bahler, H J Verberne, E Brakema, R Tepaske, J Booij, J B Hoekstra, F Holleman

Publikováno v: Endocrine Connections, Vol 5, Iss 6, Pp 44-52 (2016)

Bromocriptine is a glucose-lowering drug, which was shown to be effective in obese subjects with insulin resistance. It is usually administered in the morning. The exact working mechanism of bromocriptine still has to be elucidated. Therefore, in thi

Externí odkaz: https://doaj.org/article/209db856c2a4430b967c3cfb5bb68289

Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects article

Autor: Kristien E. C. Bouter, K. Willems van Dijk, Albert K. Groen, Hein J. Verberne, Ruud S. Kootte, Evgeni Levin, Mireille J. Serlie, S. Katiraei, Mariëtte T. Ackermans, Johannes A. Romijn, Frits Holleman, Shanthadevi D. Udayappan, Guido J. Bakker, Pim W. Gilijamse, Marcus Ståhlman, Geesje M. Dallinga-Thie, Fredrik Bäckhed, E. M. Kemper, Annick V. Hartstra, Valentina Tremaroli, L. Bahler, N.A.W. van Riel, M. Nieuwdorp

Publikováno v: Clinical and translational gastroenterology, 9(5):155. Nature Publishing Group
Clinical and Translational Gastroenterology
Clinical and translational gastroenterology, 9:155. Nature Publishing Group
Clinical and Translational Gastroenterology, 9
Clinical and Translational Gastroenterology, 9(5):155. Nature Publishing Group

Background: Gut microbiota-derived short-chain fatty acids (SCFAs) have been associated with beneficial metabolic effects. However, the direct effect of oral butyrate on metabolic parameters in humans has never been studied. In this first in men pilo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cfcdf6cd103d1018cf3cd6bb3b3a9f4
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85047626228&origin=inward

An old male with multiple hotspots on

Autor: L, Bahler, F, Holleman, H J, Verberne

Publikováno v: The Netherlands journal of medicine. 75(1)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3f0de19ce0ecb209335f57921e81ef15
https://pubmed.ncbi.nlm.nih.gov/28124674

The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus

Autor: Victor E. A. Gerdes, E. J. van den Dool, Joost B. L. Hoekstra, Pieter Willem Kamphuisen, Rienk Nieuwland, B. A. Lemkes, An K. Stroobants, L. Bahler, Frits Holleman

Publikováno v: Journal of thrombosis and haemostasis, 10(4), 639-646. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 10(4), 639-646. Wiley

Summary. Background: Low-dose aspirin seems to offer no benefit in the primary prevention of cardiovascular disease in type 2 diabetes mellitus (DM2). The anti-platelet effect may be diminished by poor glycemic control or inadequate dosing of aspirin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8310dfc28cd0b119059786dac7688d0b
https://doi.org/10.1111/j.1538-7836.2012.04632.x

Differential contribution of prosodic cues in the native and non-native segmentation of French speech

Autor: Annie Tremblay, Carly L. Bahler, Caitlin E. Coughlin, Stéphanie Gaillard

Publikováno v: Laboratory Phonology. 3

This study investigates the use of prosodic information in the segmentation of French speech by mid-level and high-level English second/foreign language (L2) learners of French and native French listeners. The results of two word- monitoring tasks, o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::19032ddbab93be8ac567b7644b951eb4
https://doi.org/10.1515/lp-2012-0018